T, D. M., NQ, L., C, S., MA, T., M, S., MP, L., . . . A, U. (2016). 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer. Molecular oncology, 10(1), 24. https://doi.org/10.1016/j.molonc.2015.07.004
Chicago Style (17th ed.) CitationT, De Marchi, et al. "4-protein Signature Predicting Tamoxifen Treatment Outcome in Recurrent Breast Cancer." Molecular Oncology 10, no. 1 (2016): 24. https://doi.org/10.1016/j.molonc.2015.07.004.
MLA (9th ed.) CitationT, De Marchi, et al. "4-protein Signature Predicting Tamoxifen Treatment Outcome in Recurrent Breast Cancer." Molecular Oncology, vol. 10, no. 1, 2016, p. 24, https://doi.org/10.1016/j.molonc.2015.07.004.
Warning: These citations may not always be 100% accurate.